Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Balassa K, Andrikovics H, Remenyi P, Batai A, Bors A, Kiss KP, Szilvasi A, Rajczy K, Inotai D, Gopcsa L, Lengyel L, Barta A, Reti M, Tordai A, Masszi T. Balassa K, et al. Among authors: rajczy k. Bone Marrow Transplant. 2015 Oct;50(10):1321-5. doi: 10.1038/bmt.2015.161. Epub 2015 Jul 6. Bone Marrow Transplant. 2015. PMID: 26146809
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.
Balassa K, Andrikovics H, Remenyi P, Batai A, Szilvasi A, Bors A, Kiss KP, Rajczy K, Inotai D, Torbagyi E, Lengyel L, Barta A, Gopcsa L, Tordai A, Masszi T. Balassa K, et al. Among authors: rajczy k. Hum Immunol. 2018 Jan;79(1):13-19. doi: 10.1016/j.humimm.2017.10.010. Epub 2017 Oct 31. Hum Immunol. 2018. PMID: 29080718
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Tordai A, Bors A, Kiss KP, Balassa K, Andrikovics H, Batai A, Szilvasi A, Rajczy K, Inotai D, Torbagyi E, Lengyel L, Barta A, Remenyi P, Masszi T. Tordai A, et al. Among authors: rajczy k. PLoS One. 2019 Jun 25;14(6):e0218945. doi: 10.1371/journal.pone.0218945. eCollection 2019. PLoS One. 2019. PMID: 31237928 Free PMC article.
HLA genetic diversity in Hungarians and Hungarian Gypsies: complementary differentiation patterns and demographic signals revealed by HLA-A, -B and -DRB1 in Central Europe.
Inotai D, Szilvasi A, Benko S, Boros-Major A, Illes Z, Bors A, Kiss KP, Rajczy K, Gelle-Hossó A, Buhler S, Nunes JM, Sanchez-Mazas A, Tordai A. Inotai D, et al. Among authors: rajczy k. Tissue Antigens. 2015 Aug;86(2):115-21. doi: 10.1111/tan.12600. Epub 2015 Jul 7. Tissue Antigens. 2015. PMID: 26149581
Low occurrence of the HLA-C*04:09N allele in a large Hungarian cohort.
Bors A, Inotai D, Andrikovics H, Benkő S, Boros-Major A, Illés Z, Szilvási A, Gelle-Hossó A, Rajczy K, Tordai A. Bors A, et al. Among authors: rajczy k. Tissue Antigens. 2015 Jul;86(1):32-5. doi: 10.1111/tan.12587. Epub 2015 Jun 2. Tissue Antigens. 2015. PMID: 26031704
Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state.
Barta A, Bátai A, Kelemen E, Lengyel L, Reményi P, Sipos A, Torbágyi E, Avalos M, Fekete E, Földi J, Páldi-Haris P, Tamáska J, Gyódi E, Rajczy K, Hoffer I, Jakab J, Petrányi GG, Pálóczi K. Barta A, et al. Among authors: rajczy k. Hum Immunol. 2000 Feb;61(2):101-10. doi: 10.1016/s0198-8859(99)00143-3. Hum Immunol. 2000. PMID: 10717801 Review.
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
Csuka D, Simon D, Hóbor R, Uray K, Prohászka Z, Bánlaki Z, Jani PK, Szilágyi Á, Hudecz F, Rajczy K, Beke G, Boros Major A, Tordai A, Illés Z, Berki T, Czirják L, Füst G. Csuka D, et al. Among authors: rajczy k. Clin Exp Immunol. 2013 Mar;171(3):255-62. doi: 10.1111/cei.12022. Clin Exp Immunol. 2013. PMID: 23379431 Free PMC article.
72 results